| Document Date: 2014-02-02 05:04:38
Open Document File Size: 515,83 KBShare Result on Facebook
City TGF / / Company A2a / / / Facility University of Arkansas / / IndustryTerm caffeine solution / caffeinated beverage / pro-fibrotic chemical agents / myriad chemical substances / chemical models / / MedicalCondition inflammatory cell function / liver fibrosis/cirrhosis / experimental liver fibrosis / scar / fatty liver disease / CCl4-induced liver fibrosis / disease / hepatocellular carcinoma / ultimately hepatocellular carcinoma / chronic liver disease / standard rodent liver fibrosis / TAA-induced liver fibrosis / cirrhosis / hepatitis C / animal liver fibrosis / metabolic syndrome / LIVER FIBROSIS / chronic liver diseases / lung disease / advanced fibrosis / toxin-induced liver fibrosis/cirrhosis / infection / liver injury / TAA- and CCl4-induced liver fibrosis / inflammation / inflammatory cell / hepatic decompensation / fibrosis / / Organization National Institute of Health / Division of Gastroenterology and Hepatology / University of Arkansas / / Person Harrison / Gq / Torres / Roger L. Jenkins / Jonathan A. Dranoff / / Position scientist / / Product theophylline / Hepatology / vitamin A / adenosine / / ProvinceOrState Oregon / Arkansas / / Technology alpha / /
SocialTag |
Hepatology HOW DOES COFFEE PREVENT LIVER FIBROSIS? BIOLOGICAL PLAUSIBILITY FOR RECENT EPIDEMIOLOGICAL OBSERVATIONS